NCT06208436View on ClinicalTrials.gov

The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

October 7, 2023

Primary Completion Date

February 15, 2024

Study Completion Date

February 28, 2024

Conditions
Pancreas CancerChemotherapy
Interventions
OTHER

Adjuvant chemotherapy

Patients received adjuvant chemotherapy (5-FU-based or gemcitabine-based regimens) or underwent surgery alone

Trial Locations (1)

300202

RECRUITING

Jihui, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER